CRISPR Therapeutics AG

0VRQ.L·LSE
Compare
51.30−1.06 (−2.02%)today
As of Nov 5, 11:41 AM GMT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close52.36
Open51.87
Day range51.2352.80
52-week range44.3063.43
Off day high−2.84%
Off 52-week high−19.12%
Volume124
Avg. volume (3M)5.66K
Market cap—
EPS (TTM)3.86
Forward P/E—
P/E ratio (TTM)13.29
Dividend yield—
Beta (5Y)1.90
Shares outstanding—
Short interest—
Earnings dateNov 2, 2026
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
0VRQ.L NTLA SANA CRBU EDIT SCTX
Market cap — 1.72B 766.36M 47.64M 417.74M 317.67M
P/E (TTM) 13.3 — — — — —
Forward P/E — -4.8 -4.6 -0.5 -3.6 -4.6
Price/book 3.0 2.4 5.0 0.5 4.0 -0.3
Dividend yield — — — — — —
1-year change −8.20% −0.08% −36.79% −79.25% +1.12% −11.54%
Today −2.02% +3.79% +4.92% −3.27% +4.62% +3.58%

The closest companies by business. Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to CRISPR Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Intellia Therapeutics, Inc.NTLA · Biotechnology 1.72B 12.31 +3.79%
Sana Biotechnology, Inc.SANA · Biotechnology 766.36M 2.5600 +4.92%
Caribou Biosciences, Inc.CRBU · Biotechnology 47.64M 0.4444 −3.27%
Editas Medicine, Inc.EDIT · Biotechnology 417.74M 2.7200 +4.62%
Scribe Therapeutics Inc.SCTX · Biotechnology 317.67M 16.78 +3.58%
Precision BioSciences, Inc.DTIL · Biotechnology 226.84M 8.12 +16.50%
ProQR Therapeutics N.V.PRQR · Biotechnology 198.98M 1.4100 +2.92%
Genprex, Inc.GNPX · Biotechnology 1.75M 2.1400 −7.36%

Also based in Zug, Switzerland, then elsewhere in Switzerland.

Company Mkt cap Price Today
Transocean Ltd.RIG · Zug, Switzerland 6.09B 5.45 −7.63%
Galderma Group AGGALD.SW · Zug, Switzerland 45.41B 194.75 +0.10%
Holcim AG0QKY.IL · Zug, Switzerland 45.10B 75.22 +4.33%
Amrize LtdAMRZ · Zug, Switzerland 23.51B 44.15 +5.19%
Swiss Prime Site AGSPSN.SW · Zug, Switzerland 10.67B 133.00 −0.45%
PSP Swiss Property AGPSPN.SW · Zug, Switzerland 7.14B 155.70 +0.13%
Pharvaris N.V.PHVS · Zug, Switzerland 2.41B 34.33 −1.29%
Bossard Holding AGBOSN.SW · Zug, Switzerland 2.03B 263.00 +0.77%

The stocks whose daily moves over the past year went most closely with CRISPR Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
CRISPR Therapeutics AG1CG.SG · Correlation 0.81 — 46.18 +0.60%
Intellia Therapeutics, Inc.NTLA · Correlation 0.61 1.72B 12.31 +3.79%
Editas Medicine, Inc.EDIT · Correlation 0.57 417.74M 2.7200 +4.62%
Sana Biotechnology, Inc.SANA · Correlation 0.52 766.36M 2.5600 +4.92%
BioNTech SE22UA.F · Correlation 0.43 19.88B 80.20 +0.88%
Caribou Biosciences, Inc.CRBU · Correlation 0.43 47.64M 0.4444 −3.27%
ProQR Therapeutics N.V.PRQR · Correlation 0.37 198.98M 1.4100 +2.92%
Lithium Argentina AGLAR · Correlation 0.31 689.22M 4.2000 +4.74%

What visitors to CRISPR Therapeutics's page also look at.

Company Mkt cap Price Today
CRISPR THERAPEUTICS AGCRSPN.MX 92.15B 950.00 0.00%
CRISPR THERADRNC2RS34.SA 3.36B 34.68 0.00%
CRISPR Therapeutics AG1CG.SG — 46.18 +0.60%
ILLUMINA INC.ILU.F 30.24B 199.98 −0.85%
BioNTech SE22UA.F 19.88B 80.20 +0.88%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 0VRQ.L news ›
MarketScreener··2 outletsPositive

Crispr Therapeutics Announces Appointment of Sivakesava Sakhamuri as Chief Technical Officer, Effective November 2, 2026

CRISPR Therapeutics announced the appointment of Sivakesava Sakhamuri, Ph.D., as Chief Technical Officer, effective November 2, 2026. Dr. Sakhamuri brings about 30 years of technical operations and... CRISPR Therapeutics announced the…

CRSPVRTX
More from 1 other outlet
MarketScreener·Positive

CRISPR Therapeutics AG Announces CFO Changes

CRISPR Therapeutics AG announced the promotion of Andrew J. Silver, currently the Company's SVP, Finance, to be the Company's Chief Financial Officer effective October 19, 2026. Since January 2025,... CRISPR Therapeutics AG announced the…

CRSPVRTX

From the 4Search news index, newest first.

In the news

61mentions in 30 days
61with it in the headline
Positivesentiment

Mentioned with

Crispr Therapeutics AG56Therapeutics AG56Vertex Pharmaceuticals56U.S. Food and Drug Administration51Crispr33Finance27Ernst & Young Llp21Morgan Stanley Smith Barney Llc19

People in the coverage

Casgevy52Crispr51Cathie Wood43Samarth Kulkarni32James Halley30James R. Kasinger30

Themes

Crsp58Healthcare46Biotechnology40SEC Filings38Crispr Therapeutics AG33Usmf-Health-Care23Finanzen22Form 421

Most coverage from

  1. markets.businessinsider.com9
  2. marketscreener.com7
  3. stocktitan.net6
  4. fool.com5
  5. themarketsdaily.com5

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 61 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance